BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 24138428)

  • 1. Review of rank-based procedures for multicenter clinical trials.
    Rashid MM; McKean JW; Kloke JD
    J Biopharm Stat; 2013; 23(6):1207-27. PubMed ID: 24138428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of an outcome using trajectories estimated from a linear mixed model.
    Maruyama N; Takahashi F; Takeuchi M
    J Biopharm Stat; 2009 Sep; 19(5):779-90. PubMed ID: 20183443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Many multicenter trials had few events per center, requiring analysis via random-effects models or GEEs.
    Kahan BC; Harhay MO
    J Clin Epidemiol; 2015 Dec; 68(12):1504-11. PubMed ID: 25985892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies for analyzing multilevel cluster-randomized studies with binary outcomes collected at varying intervals of time.
    Olsen MK; DeLong ER; Oddone EZ; Bosworth HB
    Stat Med; 2008 Dec; 27(29):6055-71. PubMed ID: 18825655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A rank-based mixed model approach to multisite clinical trials.
    Boos DD; Brownie C
    Biometrics; 1992 Mar; 48(1):61-72. PubMed ID: 1581494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Empirical shrinkage estimator for consistency assessment of treatment effects in multi-regional clinical trials.
    Quan H; Li M; Shih WJ; Ouyang SP; Chen J; Zhang J; Zhao PL
    Stat Med; 2013 May; 32(10):1691-706. PubMed ID: 22855311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A powerful and robust test statistic for randomization inference in group-randomized trials with matched pairs of groups.
    Zhang K; Traskin M; Small DS
    Biometrics; 2012 Mar; 68(1):75-84. PubMed ID: 21732926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The benefit of stratification in clinical trials revisited.
    Ganju J; Zhou K
    Stat Med; 2011 Oct; 30(24):2881-9. PubMed ID: 21905064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rank-based tests for non-inferiority and equivalence hypotheses in multi-centre clinical trials using mixed models.
    Rashid MM
    Stat Med; 2003 Jan; 22(2):291-311. PubMed ID: 12520563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An urn model for odds-ratio-based response-adaptive phase III clinical trials for two or more treatments.
    Basak GK; Biswas A; Volkov S
    J Biopharm Stat; 2009 Sep; 19(5):838-56. PubMed ID: 20183447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stratified experiments reexamined with emphasis on multicenter trials.
    Ganju J; Mehrotra DV
    Control Clin Trials; 2003 Apr; 24(2):167-81. PubMed ID: 12689738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Robust model fitting for the non linear structural equation model under normal theory.
    Xia YM; Song XY; Lee SY
    Br J Math Stat Psychol; 2009 Nov; 62(Pt 3):529-68. PubMed ID: 19040790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intention-to-treat analyses for incomplete repeated measures data.
    Hogan JW; Laird NM
    Biometrics; 1996 Sep; 52(3):1002-17. PubMed ID: 8805765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new population-enrichment strategy to improve efficiency of placebo-controlled clinical trials of antidepressant drugs.
    Merlo-Pich E; Alexander RC; Fava M; Gomeni R
    Clin Pharmacol Ther; 2010 Nov; 88(5):634-42. PubMed ID: 20861834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maximum likelihood estimation in survival studies under progressive interval censoring with random removals.
    Xiang L; Tse SK
    J Biopharm Stat; 2005; 15(6):981-91. PubMed ID: 16279356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Robust analysis of a mixed-effect model for a multicenter clinical trial.
    Patel HI
    J Biopharm Stat; 2002 Feb; 12(1):21-37. PubMed ID: 12146718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjusting for regression toward the mean when variables are normally distributed.
    Lin HM; Hughes MD
    Stat Methods Med Res; 1997 Jun; 6(2):129-46. PubMed ID: 9261912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of longitudinal clinical trials with missing data using multiple imputation in conjunction with robust regression.
    Mehrotra DV; Li X; Liu J; Lu K
    Biometrics; 2012 Dec; 68(4):1250-9. PubMed ID: 22994905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of the bootstrap in analysing cost data from cluster randomised trials: some simulation results.
    Flynn TN; Peters TJ
    BMC Health Serv Res; 2004 Nov; 4(1):33. PubMed ID: 15550169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extension of the rank sum test for clustered data: two-group comparisons with group membership defined at the subunit level.
    Rosner B; Glynn RJ; Lee ML
    Biometrics; 2006 Dec; 62(4):1251-9. PubMed ID: 17156300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.